Question

Difficulty: MediumGynecologic Infections

A 27-year-old nulliparous woman at 15 weeks gestation comes to the clinic for a scheduled prenatal visit. She reports feeling well and has no current health concerns. Upon specific questioning, she denies any vaginal itching, burning, malodor, or pelvic pain. Her vital signs are within normal limits. Speculum examination reveals a normal-appearing, closed cervix and a moderate amount of thin, homogenous, grayish-white vaginal discharge pooling in the posterior fornix. The patient states this discharge has been present for several weeks but does not bother her. Point-of-care testing of the vaginal fluid demonstrates a pH of 5.5. Addition of 10% potassium hydroxide to the fluid produces a strong amine odor. Microscopic evaluation of a saline wet mount reveals numerous sloughed squamous epithelial cells with their margins completely obscured by adherent coccobacilli. Which of the following is the most appropriate next step in management?

  1. Continue routine prenatal care without pharmacotherapyAnswer
  2. B
    Prescribe a seven-day course of oral metronidazole for the patient
  3. C
    Prescribe a seven-day course of intravaginal clindamycin
  4. D
    Prescribe oral metronidazole for both the patient and her sexual partner
  5. E
    Prescribe a single dose of oral fluconazole

Answer

The most appropriate management is to continue routine prenatal care without pharmacotherapy, as treating asymptomatic bacterial vaginosis in pregnancy is not recommended.
The correct approach is expectant management (continuing routine prenatal care without pharmacotherapy). This patient's presentation fulfills all four Amsel criteria for bacterial vaginosis (BV): homogenous discharge, pH > 4.5, positive amine odor, and clue cells. However, she is entirely asymptomatic. In pregnant women, routine treatment of asymptomatic BV is not recommended because clinical trials have shown it does not reduce the risk of preterm labor or other adverse obstetric outcomes. Therefore, observation is the standard of care.

### Vaginitis Management Summary
ConditionVaginal pHMicroscopic FindingsManagement in Pregnancy
Bacterial Vaginosis> 4.5Clue cellsTreat only if symptomatic
Vulvovaginal Candidiasis4.0 - 4.5Pseudohyphae, budding yeastTopical azoles (avoid oral fluconazole)
Trichomoniasis> 4.5Motile, flagellated protozoaOral metronidazole

Step-by-Step Solution

1
Diagnose the vaginal discharge based on clinical and microscopic findings.
The patient has thin, homogenous discharge, a pH > 4.5, a positive whiff test, and clue cells on wet mount. These fulfill Amsel criteria, confirming the diagnosis of bacterial vaginosis (BV).
Accurate identification of the vaginal dysbiosis is required before determining management.
2
Assess the patient's symptomatic status and obstetric context.
The patient is at 15 weeks gestation and explicitly denies any bothersome symptoms (no itching, burning, or malodor from her perspective).
The necessity of treating BV heavily depends on whether the patient is symptomatic and her pregnancy status.
3
Apply current treatment guidelines for bacterial vaginosis in pregnancy.
Guidelines recommend against screening for and treating asymptomatic BV in pregnant women, as antibiotic therapy has not been shown to prevent preterm delivery or other adverse outcomes in this population.
Antibiotic stewardship dictates avoiding unnecessary pharmacotherapy, especially during pregnancy when fetal exposure is a consideration.

Key Concept

Asymptomatic Bacterial Vaginosis in Pregnancy
Rate this question